PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
about
The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancerMinority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
P2860
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@ast
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@en
type
label
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@ast
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@en
prefLabel
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@ast
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
@en
P2093
P2860
P356
P1433
P1476
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2016.93
P407
P577
2016-04-04T00:00:00Z
P6179
1050181919